Rennova Health Inc (RNVA)
0.0001
0.00 (0.00%)
USD |
OTCM |
Apr 19, 12:10
Rennova Health Total Liabilities (Quarterly): 50.20M for Sept. 30, 2022
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
September 30, 2022 | 50.20M |
June 30, 2022 | 47.80M |
March 31, 2022 | 47.58M |
September 30, 2021 | 58.01M |
June 30, 2021 | 60.97M |
March 31, 2021 | 64.12M |
December 31, 2020 | 61.28M |
September 30, 2020 | 55.63M |
June 30, 2020 | 76.53M |
March 31, 2020 | 98.05M |
December 31, 2019 | 91.23M |
September 30, 2019 | 84.24M |
June 30, 2019 | 72.58M |
March 31, 2019 | 63.51M |
December 31, 2018 | 53.37M |
September 30, 2018 | 49.57M |
June 30, 2018 | 146.19M |
March 31, 2018 | 190.05M |
December 31, 2017 | 46.90M |
September 30, 2017 | 25.15M |
June 30, 2017 | 23.20M |
March 31, 2017 | 73.65M |
December 31, 2016 | 21.37M |
September 30, 2016 | 20.24M |
June 30, 2016 | 29.29M |
Date | Value |
---|---|
March 31, 2016 | 27.90M |
September 30, 2015 | 0.936M |
June 30, 2015 | 1.355M |
March 31, 2015 | 1.373M |
December 31, 2014 | 1.378M |
September 30, 2014 | 1.35M |
June 30, 2014 | 1.636M |
March 31, 2014 | 1.39M |
December 31, 2013 | 1.401M |
September 30, 2013 | 1.343M |
June 30, 2013 | 1.293M |
March 31, 2013 | 1.278M |
December 31, 2012 | 1.456M |
September 30, 2012 | 1.651M |
June 30, 2012 | 0.439M |
March 31, 2012 | 0.582M |
December 31, 2011 | 0.538M |
September 30, 2011 | 0.904M |
June 30, 2011 | 1.295M |
March 31, 2011 | 1.792M |
December 31, 2010 | 3.232M |
September 30, 2010 | 1.821M |
June 30, 2010 | 2.967M |
March 31, 2010 | 4.366M |
December 31, 2009 | 5.313M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
47.58M
Minimum
Mar 2022
98.05M
Maximum
Mar 2020
66.79M
Average
61.28M
Median
Dec 2020
Total Liabilities (Quarterly) Benchmarks
CEL-SCI Corp | 16.06M |
AIM ImmunoTech Inc | 9.147M |
IGC Pharma Inc | 2.206M |
NovaBay Pharmaceuticals Inc | 5.72M |
Protalix BioTherapeutics Inc | 50.86M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 20.29M |
Shareholders Equity (Quarterly) | -29.91M |